Brief: Irlab Therapeutics Gets Approval From Swedish Medical Products Agency

IRLAB Therapeutics AB

06/05/2024 06:04

May 6 (Reuters) - IRLAB Therapeutics AB  IRLABa.ST :
    * HAS RECEIVED APPROVAL FROM SWEDISH MEDICAL PRODUCTS AGENCY
TO
CONDUCT A PHASE I STUDY OF DRUG CANDIDATE IRL757

Source text for Eikon:  ID:nMFN8H7skp 
Further company coverage:  IRLABa.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))